These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12953784)

  • 1. Memory enhancement: the progress and our fears.
    Gerlai R
    Genes Brain Behav; 2003 Aug; 2(4):187-8; discussion 189-90. PubMed ID: 12953784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroethical issues in cognitive enhancement.
    Sahakian BJ; Morein-Zamir S
    J Psychopharmacol; 2011 Feb; 25(2):197-204. PubMed ID: 20212064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive enhancement: what can we do and what should we do?
    Farah MJ; Illes J; Cook-Deegan R; Gardner H; Kandel E; King P; Parens E; Sahakian B; Wolpe PR
    Nat Rev Neurosci; 2004 May; 5(5):421-5. PubMed ID: 15100724
    [No Abstract]   [Full Text] [Related]  

  • 4. Experts urge smart thinking on cognitive enhancers.
    Morris K
    Lancet Neurol; 2008 Jun; 7(6):476-7. PubMed ID: 18485312
    [No Abstract]   [Full Text] [Related]  

  • 5. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part III. Developmental disorders, alternative approaches, and emerging technologies.
    Handb Exp Pharmacol; 2015; 228():305-7. PubMed ID: 26317141
    [No Abstract]   [Full Text] [Related]  

  • 7. Verbal memory.
    Sumiyoshi T
    Handb Exp Pharmacol; 2015; 228():237-47. PubMed ID: 25977085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards responsible use of cognitive-enhancing drugs by the healthy.
    Greely H; Sahakian B; Harris J; Kessler RC; Gazzaniga M; Campbell P; Farah MJ
    Nature; 2008 Dec; 456(7223):702-5. PubMed ID: 19060880
    [No Abstract]   [Full Text] [Related]  

  • 9. Humility pills: building an ethics of cognitive enhancement.
    Goodman R
    J Med Philos; 2014 Jun; 39(3):258-78. PubMed ID: 24847120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Just treat, or enhance?
    Kennedy D
    Science; 2004 Apr; 304(5667):17. PubMed ID: 15060288
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards better brain management: nootropics.
    Malik R; Sangwan A; Saihgal R; Jindal DP; Piplani P
    Curr Med Chem; 2007; 14(2):123-31. PubMed ID: 17266573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging cognitive enhancing drugs.
    Buccafusco JJ
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):577-89. PubMed ID: 19772371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical issues in the use of cognitive enhancement.
    Darby R
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(2):16-22. PubMed ID: 20455376
    [No Abstract]   [Full Text] [Related]  

  • 14. Declarative memory.
    Riedel WJ; Blokland A
    Handb Exp Pharmacol; 2015; 228():215-36. PubMed ID: 25977084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing cognition through pharmacological and environmental interventions: Examples from preclinical models of neurodevelopmental disorders.
    Morè L; Lauterborn JC; Papaleo F; Brambilla R
    Neurosci Biobehav Rev; 2020 Mar; 110():28-45. PubMed ID: 30981451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A focus group on cognition-enhancing medications in Alzheimer disease: disparities between professionals and consumers.
    Post SG; Stuckey JC; Whitehouse PJ; Ollerton S; Durkin C; Robbins D; Fallcreek SJ
    Alzheimer Dis Assoc Disord; 2001; 15(2):80-8. PubMed ID: 11391089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive regeneration or enhancement: the ethical issues.
    Chan S; Harris J
    Regen Med; 2006 May; 1(3):361-6. PubMed ID: 17465790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part II. Cognitive domains for pharmacological intervention: implications for neuropsychiatric and neurological illnesses.
    Handb Exp Pharmacol; 2015; 228():157-9. PubMed ID: 26317140
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?
    Stiles MM; Martin S; Persons RK
    J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroethics of pharmaceutical cognitive enhancement: the first ten years: current problems and practical guiding principles].
    Metzinger TK
    Fortschr Neurol Psychiatr; 2012 Jan; 80(1):36-43. PubMed ID: 22234814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.